NYSEARCA:BBP Virtus LifeSci Biotech Products ETF (BBP) Price, Holdings, & News $72.15 -0.01 (-0.01%) Closing price 04:10 PM EasternExtended Trading$72.26 +0.10 (+0.15%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BBP alerts:Sign Up Key Stats Today's Range$72.11▼$72.6950-Day Range$61.53▼$72.1652-Week Range$48.65▼$72.69Volume5,538 shsAverage Volume2,862 shsMarket Capitalization$28.86 millionAssets Under Management$28.87 millionDividend YieldN/ANet Expense Ratio0.79%Aggregate RatingModerate Buy ETF Overview The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus. Read More Virtus LifeSci Biotech Products ETF ExpensesTypeBBPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.79%0.56%0.56%0.51%0.53%Other Expenses0.00%0.47%0.56%0.59%0.56%Total Expense0.79%0.75%0.76%0.74%0.73%Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%Net Expense0.79%0.60%0.63%0.58%0.60% Receive BBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Products ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBP ETF News HeadlinesVirtus LifeSci Biotech Clinical Trials ETF declares annual distribution of $0.2394December 23, 2024 | msn.comCanadian ETF Comparison Series: FCUQ vs. ZUQ.FDecember 17, 2024 | theglobeandmail.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.October 9 at 2:00 AM | Brownstone Research (Ad)BBP Virtus LifeSci Biotech Products ETFOctober 9, 2024 | seekingalpha.comVirtus LifeSci Biotech Products ETF (BBP)August 25, 2024 | investing.comVirtus LifeSci Biotech Clinical Trials ETF (BBC)August 16, 2024 | investing.comSee More Headlines BBP ETF - Frequently Asked Questions How have BBP shares performed this year? Virtus LifeSci Biotech Products ETF's stock was trading at $60.02 at the beginning of 2025. Since then, BBP shares have increased by 20.2% and is now trading at $72.15. How do I buy shares of Virtus LifeSci Biotech Products ETF? Shares of BBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Virtus LifeSci Biotech Products ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Products ETF investors own include Inovio Pharmaceuticals (INO), Micron Technology (MU), Sanofi (SNY), Gilead Sciences (GILD), Simon Property Group (SPG), Intel (INTC) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Fund Details IssuerVirtus Fund NameVirtus LifeSci Biotech Products ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BBP Inception Date12/16/2014 Fund ManagerMatthew B. Brown, Seth Kadushin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci Biotechnology Products Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings59 Fund Statistics Assets Under Management$28.87 million Average Daily Volume$4.35 thousand Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorVirtus ETF Solutions, LLC AdvisorVirtus ETF Advisers, LLC CustodianThe Bank of New York Mellon Corporation DistributorETF Distributors LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume6 Put Options6 Call Options12 Short Interest600 shs Miscellaneous Outstanding Shares400,000Beta0.73 Creation Unit50,000 Creation Fee$500.00 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report Top 10 BBP HoldingsIonis Pharmaceuticals (NASDAQ:IONS)Holding Weight: 2.89%Travere Therapeutics (NASDAQ:TVTX)Holding Weight: 2.60%CRISPR Therapeutics (NASDAQ:CRSP)Holding Weight: 2.51%Rhythm Pharmaceuticals (NASDAQ:RYTM)Holding Weight: 2.48%Ligand Pharmaceuticals (NASDAQ:LGND)Holding Weight: 2.45%United Therapeutics (NASDAQ:UTHR)Holding Weight: 2.39%Insmed (NASDAQ:INSM)Holding Weight: 2.38%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 2.37%Madrigal Pharmaceuticals (NASDAQ:MDGL)Holding Weight: 2.36%Mirum Pharmaceuticals (NASDAQ:MIRM)Holding Weight: 2.33%Full Holdings DetailsBBP Sector ExposureBBP Industry Exposure This page (NYSEARCA:BBP) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
